PCVX
Vaxcyte, Inc.Healthcare$58.38
▼ Bearish
Mkt Cap: $8.48B|Float: 132.2M|SI: 9.9%|DTC: 10.6
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
35.9%
52W Range
$28-$65
ATR(14)
$2.33
Exp. Move
±10.1%
P/C Ratio
2.30
Earnings
May 6
GEX Negative
DEX Long
Net Put Premium
IV High
Max Pain Below
Exp. Move Wide
High Put/Call
PCVX Key Options Data
- IV Rank
- 100%
- Total GEX
- $-0.00B
- Total DEX
- $1.5M
- Max Pain
- $55.00
- Expected Move
- ±10.1%
- Put/Call OI
- 2.30
- Net Premium
- $-2.9M
- Spot Price
- $58.38
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$5.90 | ±10.1% | $52.48 | $64.28 |
| 2026-05-15 | 43 | ±$3.75 | ±6.4% | $54.63 | $62.13 |
| 2026-07-17 | 106 | ±$13.10 | ±22.4% | $45.28 | $71.48 |
| 2026-10-16 | 197 | ±$10.70 | ±18.3% | $47.68 | $69.08 |
| 2026-12-18 | 260 | ±$47.55 | ±81.5% | $10.83 | $105.93 |
| 2027-01-15 | 288 | ±$47.25 | ±80.9% | $11.13 | $105.63 |
Explore PCVX options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.